Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

被引:0
作者
Mangieri, Christopher W. [1 ]
Valenzuela, Cristian D. [1 ]
Solsky, Ian B. [1 ]
Erali, Richard A. [1 ]
Votanopoulos, Konstantinos, I [1 ]
Shen, Perry [1 ]
Levine, Edward A. [1 ]
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Baptist Hlth Med Ctr, Sect Surg Oncol, Med Ctr Blvd, Winston Salem, NC 27157 USA
关键词
cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; hysterectomy; myometrium; peritoneal carcinomatosis; Peritoneal dissemination; PERITONEAL CANCER INDEX; VASCULAR SPACE INVASION; ENDOMETRIAL CARCINOMA; PATIENT SELECTION; PLUS HIPEC; INVOLVEMENT; MRI; PCI;
D O I
10.1002/jso.27122
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is an effective surgical intervention for peritoneal surface malignancy. The effect of myometrium invasion on outcomes is unknown. Methods Retrospective review of our institutional registry with analysis of CRS-HIPEC cases involving a hysterectomy. Compared cases with myometrium invasion versus those without invasion. Primary outcome was survival as measured by overall survival (OS) and disease-free survival (DFS). Secondary outcome was the evaluation of risk factors for myometrium invasion based on multivariate analysis. Results A total of 126 cases of CRS-HIPEC involving a hysterectomy were identified. Ninety-seven cases (76.9%) had no myometrium invasion and the remaining 29 cases (23.1%) had malignant invasion. The presence of myometrial invasion was a significant negative survival prognostic factor. The OS was halved with mean survival times of 2.8 (+/- 2.3) versus 5.8 (+/- 4.7) years for cases with and without invasion, respectively (p = 0.002). Five-year OS rates were also inferior with myometrium invasion at 17.4% versus 53.8% (odds ratio [OR] = 0.181, 95% confidence interval [CI]: 0.057-0.580, p = 0.002). A similar trend was present with DFS with mean survival times of 1.4 (+/- 0.9) versus 3.7 (+/- 3.9) years for noninvasion and invasion cases (p = 0.009). The 5-year DFS rates were 0% versus 34.8% (OR = 0.652, 95% CI: 0.549-0.775, p = 0.004). Secondary analysis significantly associated several risk factors with myometrium invasion to include lymph node positivity (OR = 2.539, 95% CI: 1.074-6.003, p = 0.012), colorectal primary tumors (OR = 2.248, 95% CI: 1.094-5.161, p = 0.035), and high-grade tumors (OR = 2.160, 95% CI: 1.080-4.820, p = 0.038). Conclusion Myometrium invasion is a significant negative prognostic factor for survival following CRS-HIPEC. Several risk factors are potentially predictive of identifying those at high-risk for myometrium invasion.
引用
收藏
页码:450 / 456
页数:7
相关论文
共 26 条
[1]   Outcomes With Cytoreductive Surgery and HIPEC for Peritoneal Metastasis [J].
Ahmed, Shuja ;
Stewart, John H. ;
Shen, Perry ;
Votanopoulos, Konstantinos I. ;
Levine, Edward A. .
JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (05) :575-584
[2]   Preoperative assessment of myometrial and cervical invasion in endometrial carcinoma by transvaginal ultrasound [J].
Akbayir, Ozgur ;
Corbacioglu, Aytul ;
Numanoglu, Ceyhun ;
Guleroglu, Filiz Yarsilikal ;
Ulker, Volkan ;
Akyol, Alparslan ;
Guraslan, Birgul ;
Odabasi, Engin .
GYNECOLOGIC ONCOLOGY, 2011, 122 (03) :600-603
[3]   Small bowel involvement is a prognostic factor in colorectal carcinomatosis treated with complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy [J].
Benizri, Emmanuel I. ;
Bernard, Jean-Louis ;
Rahili, Amine ;
Benchimol, Daniel ;
Bereder, Jean-Marc .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
[4]   Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer - A pooled analysis of PORTEC 1 and 2 trials [J].
Bosse, Tjalling ;
Peters, Elke E. M. ;
Creutzberg, Carien L. ;
Jurenliemk-Schulz, Ina M. ;
Jobsen, Jan J. ;
Mens, Jan Willem M. ;
Lutgens, Ludy C. H. W. ;
van der Steen-Banasik, Elzbieta M. ;
Smit, Vincent T. H. B. M. ;
Nout, Remi A. .
EUROPEAN JOURNAL OF CANCER, 2015, 51 (13) :1742-1750
[5]   The Chicago Consensus on Peritoneal Surface Malignancies: Standards [J].
Plana A. ;
Izquierdo F.J. ;
Schuitevoerder D. ;
Abbott D.E. ;
Abdel-Misih S. ;
Ahrendt S.A. ;
Al-kasspooles M. ;
Amersi F. ;
Arrington A.K. ;
Badgwell B. ;
Barone R.M. ;
Baumgartner J.M. ;
Berri R.N. ;
Bijelic L. ;
Bowne W.B. ;
Blazer D.G., III ;
Brown C.K. ;
Catenacci D.V. ;
Chan C.H.F. ;
Cho C.S. ;
Choudry M.H.A. ;
Clarke C.N. ;
Cusack J.C., Jr. ;
Dachman A.H. ;
Deneve J.L. ;
Dineen S.P. ;
Eng O.S. ;
Fernandez L.J. ;
Fleshman J. ;
Gamblin T.C. ;
Gangi A. ;
Georgakis G.V. ;
Gilbert E.W. ;
Goodman M.D. ;
Govindarajan A. ;
Grotz T.E. ;
Gushchin V. ;
Hanna N. ;
Harmath C. ;
Hart J. ;
Hayes-Jordan A. ;
Husain A.N. ;
Idrees K. ;
Ihemelandu C. ;
In H. ;
Johnston F.M. ;
Jiang D. ;
Kane J.M., III ;
Karakousis G. ;
Kelly K.J. .
ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (06) :1743-1752
[6]   Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC) [J].
Chouliaras, Konstantinos ;
Levine, Edward A. ;
Fino, Nora ;
Shen, Perry ;
Votanopoulos, Konstantinos I. .
ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (04) :890-897
[7]   Usefulness of DWI in preoperative assessment of deep myometrial invasion in patients with endometrial carcinoma: a systematic review and meta-analysis [J].
Das, Sushant K. ;
Niu, Xiang K. ;
Wang, Jing L. ;
Zeng, Li C. ;
Wang, Wen X. ;
Bhetuwal, Anup ;
Yang, Han F. .
CANCER IMAGING, 2014, 14
[8]   Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin [J].
Elias, D. ;
Mariani, A. ;
Cloutier, A. -S. ;
Blot, F. ;
Goere, D. ;
Dumont, F. ;
Honore, C. ;
Billard, V. ;
Dartigues, P. ;
Ducreux, M. .
EJSO, 2014, 40 (11) :1467-1473
[9]   Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study [J].
Elias, Dominique ;
Gilly, Francois ;
Boutitie, Florent ;
Quenet, Francois ;
Bereder, Jean-Marc ;
Mansvelt, Baudouin ;
Lorimier, Gerard ;
Dube, Pierre ;
Glehen, Olivier .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :63-68
[10]  
Gadducci A, 2009, ANTICANCER RES, V29, P1715